Novelix Pharmaceuticals Limited Announces Unanimous Approval of EGM Resolutions
Published on: Jan. 10, 2026, 7:14 p.m. | Source: scanx.trade
Novelix Pharmaceuticals Limited successfully conducted its Extra Ordinary General Meeting on January 09, 2026, through video conferencing with both proposed resolutions receiving unanimous shareholder approval. The meeting addressed equity share issuance on preferential basis and director appointment confirmation, with 86 shareholders participating in e-voting representing 62.87% of outstanding shares. All 10,147,138 votes cast were in favor of both resolutions, demonstrating strong shareholder confidence in the company's strategic decisions.
